ND BioSciences is developing proprietary platforms, technologies, reagents and tools to enable the discovery and validation of novel biochemical and imaging biomarkers and both antibody and small molecule therapies.
ND BioSciences has developed powerful proprietary technologies and innovative tools that enable for the first time reproducing, at both the biochemical and structural levels, the proteoforms and pathological species found in the brain and biological fluids of patients suffering from neurodegenerative diseases.
19.05.2023
Cash and honorary awards for Swiss innovators (startupticker.ch)
19.04.2023
Ten biotech startups head to Boston (startupticker.ch)
11.10.2022
Biopôle Funding for Limula and ND Biosciences (startupticker.ch)
18.01.2022
ND Biosciences Awarded Grant from Michael J. Fox Foundation (startupticker.ch)
12.10.2021
Joining forces with new and existing partners (startupticker.ch)
No milestones
No Jobs
No videos and documents
Website:
nd-biosciences.com/
Headquarter:
Epalinges
Foundation Date:
March 2019
Technology:
Sectors: